Virtu KCG Holdings’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Virtu KCG Holdings’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-109,634	Closed	-$17K	–	4129
2016 Q3	$17K	Buy	+109,634	New	+$25.3K	﹤0.01%	2935
2015 Q3	–	Sell	-22,052	Closed	-$52K	–	4148
2015 Q2	$52K	Buy	22,052 +2,518	+13%	+$7.77K	﹤0.01%	3054
2015 Q1	$86K	Buy	19,534 +8,760	+81%	+$44K	﹤0.01%	2695
2014 Q4	$52K	Buy	+10,774	New	+$48.2K	﹤0.01%	3420
2014 Q1	–	Sell	-11,078	Closed	-$105K	–	4392
2013 Q4	$105K	Buy	+11,078	New	+$86.4K	﹤0.01%	3421

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Virtu KCG Holdings's TLOG Position: Q4 2016 in Review

Virtu KCG Holdings sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 109,634 shares — an estimated $17K sold.

Virtu KCG Holdings first reported a position in TLOG in Q4 2013 and held it in 5 quarters. The position peaked at $105K in Q4 2013. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Virtu KCG Holdings reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Virtu KCG Holdings sold 109,634 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $17K.
Virtu KCG Holdings first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2013 and held it in 5 quarters.
Virtu KCG Holdings's TetraLogic Pharmaceuticals Corporation position peaked at $105K in Q4 2013.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Virtu KCG Holdings's 13F filing for Q4 2016, filed 10 Feb 2017.